---  
layout: startup_page  
title: "SynOx Therapeutics Limited"  
id: "synoxtherapeutics.com"  
permalink: "/synoxtherapeuticslimitedsynoxtherapeutics.com04222024/"  
website: "https://synoxtherapeutics.com/"  
funding_round: "Series B"  
funding_amount: "$75M"  
investors: "Forbion, HealthCap, Bioqube Ventures"  
about: "SynOx Therapeutics is a late-stage clinical biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of Tenosynovial Giant Cell Tumour (TGCT) and other macrophage-driven disorders. The company focuses on providing effective therapies for rare and debilitating diseases with a focus on improving patient quality of life. Emactuzumab has shown significant clinical activity in earlier trials."  
markets: "Biopharmaceutical, Oncology, Biotechnology"  
hq: "Dublin, County Dublin, Ireland"  
founded_year: "2020"  
linkedin: "https://ie.linkedin.com/company/synox-therapeutics"  
twitter: ""  
instagram: ""  
facebook: "https://www.facebook.com/SynOxTherapeutics"  
crunchbase: "https://www.crunchbase.com/organization/synox-therapeutics"  
pitchbook: ""  

date_display: "22-Apr-2024"  
date: "2024-04-22"

# SEO Optimization  
meta_title: "SynOx Therapeutics Limited - Series B Funding ($75M)"  
meta_description: "SynOx Therapeutics Limited, SynOx Therapeutics is a late-stage clinical biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for ..."  
meta_keywords: "SynOx Therapeutics Limited, Biopharmaceutical, Oncology, Biotechnology, Series B funding"  
canonical_url: "https://startup.projectstartups.com/synoxtherapeuticslimitedsynoxtherapeutics.com04222024/"  
---